Deborah J Andrews - Net Worth and Insider Trading
Deborah J Andrews Net Worth
The estimated net worth of Deborah J Andrews is at least $916,856 dollars as of 2024-11-13. Deborah J Andrews is the CFO of Staar Surgical Co and owns about 31,267 shares of Staar Surgical Co (STAA) stock worth over $907,368. Deborah J Andrews is also the Director of Lineage Cell Therapeutics Inc and owns about 10,000 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $9,488. Details can be seen in Deborah J Andrews's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Deborah J Andrews has not made any transactions after 2020-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Deborah J Andrews
Deborah J Andrews Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deborah J Andrews owns 2 companies in total, including Lineage Cell Therapeutics Inc (LCTX) , and Staar Surgical Co (STAA) .
Click here to see the complete history of Deborah J Andrews’s form 4 insider trades.
Insider Ownership Summary of Deborah J Andrews
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2018-09-11 | director |
| STAA | Staar Surgical Co | 2020-03-23 | VP & Chief Financial Officer |
Deborah J Andrews Latest Holdings Summary
Deborah J Andrews currently owns a total of 2 stocks. Among these stocks, Deborah J Andrews owns 31,267 shares of Staar Surgical Co (STAA) as of March 23, 2020, with a value of $907,368 and a weighting of 98.97%. Deborah J Andrews also owns 10,000 shares of Lineage Cell Therapeutics Inc (LCTX) as of September 11, 2018, with a value of $9,488 and a weighting of 1.03%.
Latest Holdings of Deborah J Andrews
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STAA | Staar Surgical Co | 2020-03-23 | 31,267 | 29.02 | 907,368 |
| LCTX | Lineage Cell Therapeutics Inc | 2018-09-11 | 10,000 | 0.95 | 9,488 |
Holding Weightings of Deborah J Andrews
Deborah J Andrews Form 4 Trading Tracker
According to the SEC Form 4 filings, Deborah J Andrews has made a total of 2 transactions in Staar Surgical Co (STAA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Staar Surgical Co is the sale of 834 shares on March 23, 2020, which brought Deborah J Andrews around $22,868.
According to the SEC Form 4 filings, Deborah J Andrews has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 1,604 shares on September 11, 2018, which cost Deborah J Andrews around $3,769.
Insider Trading History of Deborah J Andrews
- 1
Deborah J Andrews Trading Performance
GuruFocus tracks the stock performance after each of Deborah J Andrews's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Deborah J Andrews is -8.01%. GuruFocus also compares Deborah J Andrews's trading performance to market benchmark return within the same time period. The performance of stocks bought by Deborah J Andrews within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Deborah J Andrews's insider trading performs compared to the benchmark.
Performance of Deborah J Andrews
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.14 | | | | | |
| Relative Return to S&P 500(%) | 4.26 | | | | | |
Deborah J Andrews Ownership Network
Ownership Network List of Deborah J Andrews
Ownership Network Relation of Deborah J Andrews
Deborah J Andrews Owned Company Details
What does Lineage Cell Therapeutics Inc do?
Who are the key executives at Lineage Cell Therapeutics Inc?
Deborah J Andrews is the director of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include Chief Financial Officer Jill Ann Howe , director & President and CEO Brian M Culley , and 10 percent owner Broadwood Partners Lp .
Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary
Over the past 18 months, Deborah J Andrews made no insider transaction in Lineage Cell Therapeutics Inc (LCTX). Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 6,730,770 shares made by Broadwood Partners Lp , a net purchase of 96,155 shares made by Don M Bailey , and a net purchase of 10,500 shares made by Jill Ann Howe .
In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 10,500 shares, with a net purchase of 10,500 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 6,857,425 shares were bought by its insiders, resulting in a net purchase of 6,857,425 shares.
Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lineage Cell Therapeutics Inc Insider Transactions
Deborah J Andrews Mailing Address
Above is the net worth, insider trading, and ownership report for Deborah J Andrews. You might contact Deborah J Andrews via mailing address: 1911 Walker Ave., Monrovia Ca 91016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
